Global /Taiwan /Healthcare /Biotechnology /6539

DV Biomed Co., Ltd.

6539

• TPEX: 6539 • Delayed

49.20TWD 0.2%

1.56 USD

As of 20 June 2026, DV Biomed Co., Ltd. has a market cap of $37.89M USD, ranking #32582 globally and #1986 in Taiwan. It ranks #2943 in the Healthcare sector, and #567 in the Biotechnology industry.

Global Rank

32582

Country Rank

1986

Sector Rank

2943

Industry Rank

567

Key Stats

Market Cap

$37.89MUSD

1.2B TWD

Enterprise Value

$29.13MUSD

921.71M TWD

Revenue (TTM)

$25.12MUSD

794.18M TWD

EBITDA (TTM)

$1.01MUSD

32.02M TWD

Net Income (TTM)

$244.67KUSD

7.74M TWD

EBITDA Margin

Profit Margin

PE Ratio

149.1

PS Ratio

1.5

PB Ratio

2.4

EV/EBITDA

18.8

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Biotechnology

CEO

Liqi Zhang open_in_new

Employees

326

Founded

2011

Website

dvbiomed.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.2%	-0.5%	-5%	-17%	-8.3%	-16%	-20%	-69%	-70%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	6539 麗彤生醫科技股份有限公司 ISIN: TW0006539000 Shares Out.: Shares Outstanding: 24.349M¹ Shares Float: 10.774M² TV: TradingView: TPEX: 6539 SA: Stock Analysis: TPEX: 6539 YF: Yahoo Finance: 6539.TWO GF: Google Finance: TPEX: 6539 BA: Barron's: 6539 MS: Morningstar: ROCO: 6539	49.20 TWD	TV: TradingView: TPEX: 6539 SA: Stock Analysis: TPEX: 6539 YF: Yahoo Finance: 6539.TWO GF: Google Finance: TPEX: 6539 BA: Barron's: 6539 MS: Morningstar: ROCO: 6539

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About DV Biomed Co., Ltd.

DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skin care; and beauty products and services. The company was founded in 2011 and is based in Taipei, Taiwan.

Similar Companies

Industry: Biotechnology (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Caliway Biopharmaceuticals Co., Ltd. TWSE: 6919	$5.46B 172.76B TWD 14K%	-	Taiwan
Pell Bio-Med Technology Co., Ltd. TWSE: 6949	$1.61B 50.93B TWD 4K%	-	Taiwan
Lin BioScience, Inc. TPEX: 6696	$1.08B 34.04B TWD 3K%	-	Taiwan
HanchorBio Inc. TWSE: 7827	$726.25M 22.97B TWD 2K%	-	Taiwan
HanchorBio Inc. TPEX: 7827	$600.25M 18.98B TWD 1K%	-	Taiwan
Locus Cell Co., Ltd. TPEX: 06891	$571.26M 18.06B TWD 1K%	-	Taiwan

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 481K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 422K%	19.0	United States
argenx SE EBR: ARGX	$47.43B 41.39B EUR 125K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.23B 68.19T KRW 117K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.27B 60.27B AUD 111K%	29.3	Australia
Lonza Group AG SIX: LONN	$41.88B 33.71B CHF 110K%	37.2	Switzerland

chevron_leftBack